Background Multiple sclerosis (MS) is a chronic, demyelinating disease of the central
nervous system that results in progressive and irreversible disability. Fatigue is one of the …

Objectives: To estimate average annual cost per multiple sclerosis (MS) patient in the US
using published estimates from the literature. Methods: A search was performed of English …

Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

Background Although the economic burden of multiple sclerosis (MS) in high-income
countries (HICs) has been extensively studied, information on the costs of MS in low-and …

Introduction In light of the increasing number of economic burden studies and heterogeneity
in methodology and reporting standards, there is a need for robust evidence synthesis on an …

Background Survey-based studies are frequently used to describe the economic impact of
multiple sclerosis (MS). However, there is no validated health resource survey available …

Background Multiple sclerosis (MS) patients earn lower incomes and receive higher
benefits. However, there is limited knowledge of how this is correlated with their disability …

Background and Objectives Multiple sclerosis (MS), a leading cause of nontraumatic
neurologic disability in young adults, exerts a substantial economic burden on the health …

Objective: To identify evidence in the literature presenting the economic and humanistic
(based on health state utility values [HSUVs]) burden of multiple sclerosis (MS) and report …

Objectives To describe the current management patterns of multiple sclerosis (MS) patients
with spasticity in Germany and the impact of MS spasticity on quality of life (QoL) and …